Rosuvastatin calcium 20 MG Oral Tablet
1 INDICATIONS AND USAGE Rosuvastatin tablets are indicated: • To reduce the risk of stroke, myocardial infarction, and arterial revascularization procedures in adults without established coronary heart disease who are at increased risk of cardiovascular (CV) disease based on age, hsCRP ≥2 mg/L, and at least one additional CV risk factor. • As an adjunct to diet to: ∘ Reduce LDL-C in adults with primary hyperlipidemia. ∘ Reduce low-density lipoprotein cholesterol (LDL-C) and slow the progression of atherosclerosis in adults. ∘ Reduce LDL-C in adults and pediatric patients aged 8 years and older with heterozygous familial hypercholesterolemia (HeFH). • As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 7 years and older with homozygous familial hypercholesterolemia (HoFH). • As an adjunct to diet for the treatment of adults with: ∘ primary dysbetalipoproteinemia. ∘ Hypertriglyceridemia. Rosuvastatin tablets are an HMG Co‑A reductase inhibitor (statin) indicated: ( 1 ) • To reduce the risk of stroke, myocardial infarction, and arterial revascularization procedures in adults without established coronary heart disease who are at increased risk of cardiovascular (CV) disease based on age, hsCRP ≥2 mg/L, and at least one additional CV risk factor. • As an adjunct to diet to reduce LDL-C in adults with primary hyperlipidemia. • As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) and slow the progression of atherosclerosis in adults. • As an adjunct to diet to reduce LDL-C in adults and pediatric patients aged 8 years and older with heterozygous familial hypercholesterolemia (HeFH). • As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 7 years and older with homozygous familial hypercholesterolemia (HoFH). • As an adjunct to diet for the treatment of adults with: ∘ primary dysbetalipoproteinemia. ∘ Hypertriglyceridemia.
biocon pharma inc
ROUND PINK B 20
B 20 ROUND PINK
Related Pills
rosuvastatin 40 mg
biocon pharma inc
rosuvastatin 40 mg
biocon pharma inc
rosuvastatin 10 mg
biocon pharma inc
Rosuvastatin calcium 20 MG Oral Tablet
Biocon Pharma Inc
rosuvastatin 5 mg
biocon pharma inc
rosuvastatin 5 mg
biocon pharma inc
rosuvastatin calcium 10 mg
biocon pharma inc
rosuvastatin 20 mg
biocon pharma inc
baclofen 20 mg
aurobindo pharma limited
baclofen 20 mg
aurobindo pharma limited
baclofen 20 mg
aurobindo pharma limited
baclofen 20 mg
aurobindo pharma limited
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING Rosuvastatin tablets USP are supplied as: Manufacturer: Recipharm Pharmaservices Private Limited Manufacturer: Biocon Pharma Limited NDC 70377-006-11: 5 mg. yellow, round, biconvex, film-coated tablets, debossed with '5' on one side and 'B' on other side; bottle of 30 tablets NDC 70377-006-11: 5 mg. yellow, round, biconvex, film-coated tablets, debossed with '5' on one side and 'B' on other side; bottle of 30 tablets NDC 70377-006-12: 5 mg. yellow, round, biconvex, film-coated tablets, debossed with '5' on one side and 'B' on other side; bottle of 90 tablets NDC 70377-006-12: 5 mg. yellow, round, biconvex, film-coated tablets, debossed with '5' on one side and 'B' on other side; bottle of 90 tablets NDC 70377-006-13: 5 mg. yellow, round, biconvex, film-coated tablets, debossed with '5' on one side and 'B' on other side; bottle of 500 tablets NDC 70377-006-15: 5 mg. yellow, round, biconvex, film-coated tablets, debossed with '5' on one side and 'B' on other side; bottle of 1000 tablets NDC 70377-007-11: 10 mg. pink, round, biconvex, film-coated tablets, debossed with '10' on one side and 'B' on other side; bottle of 30 tablets NDC 70377-007-11: 10 mg. pink, round, biconvex, film-coated tablets, debossed with '10' on one side and 'B' on other side; bottle of 30 tablets NDC 70377-007-12: 10 mg. pink, round, biconvex, film-coated tablets, debossed with '10' on one side and 'B' on other side; bottle of 90 tablets NDC 70377-007-12: 10 mg. pink, round, biconvex, film-coated tablets, debossed with '10' on one side and 'B' on other side; bottle of 90 tablets NDC 70377-007-13: 10 mg. pink, round, biconvex, film-coated tablets, debossed with '10' on one side and 'B' on other side; bottle of 500 tablets NDC 70377-007-15: 10 mg. pink, round, biconvex, film-coated tablets, debossed with '10' on one side and 'B' on other side; bottle of 1000 tablets NDC 70377-008-11: 20 mg. pink, round, biconvex, film-coated tablets, debossed with '20' on one side and 'B' on other side; bottle of 30 tablets NDC 70377-008-11: 20 mg. pink, round, biconvex, film-coated tablets, debossed with '20' on one side and 'B' on other side; bottle of 30 tablets NDC 70377-008-12: 20 mg. pink, round, biconvex, film-coated tablets, debossed with '20' on one side and 'B' on other side; bottle of 90 tablets NDC 70377-008-12: 20 mg. pink, round, biconvex, film-coated tablets, debossed with '20' on one side and 'B' on other side; bottle of 90 tablets NDC 70377-008-13: 20 mg. pink, round, biconvex, film-coated tablets, debossed with '20' on one side and 'B' on other side; bottle of 500 tablets NDC 70377-008-15: 20 mg. pink, round, biconvex, film-coated tablets, debossed with '20' on one side and 'B' on other side; bottle of 1000 tablets NDC 70377-009-11: 40 mg. pink, oval, biconvex, film-coated tablets, debossed with '40' on one side and 'B' on other side; bottle of 30 tablets NDC 70377-009-11: 40 mg. pink, oval, biconvex, film-coated tablets, debossed with '40' on one side and 'B' on other side; bottle of 30 tablets NDC 70377-009-12: 40 mg. pink, oval, biconvex, film-coated tablets, debossed with '40' on one side and 'B' on other side; bottle of 90 tablets NDC 70377-009-12: 40 mg. pink, oval, biconvex, film-coated tablets, debossed with '40' on one side and 'B' on other side; bottle of 90 tablets NDC 70377-009-13: 40 mg. pink, oval, biconvex, film-coated tablets, debossed with '40' on one side and 'B' on other side; bottle of 500 tablets NDC 70377-009-15: 40 mg. pink, oval, biconvex, film-coated tablets, debossed with '40' on one side and 'B' on other side; bottle of 1000 tablets Storage Store at 20° to 25°C (68° to 77°F). [See USP controlled room temperature]. Protect from moisture.
More pills like ROUND B 20